Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

PIK3CA mutations are frequent in esophageal squamous cell carcinoma associated with chagasic megaesophagus and are associated with a worse patient outcome.

Munari FF, Cruvinel-Carloni A, Lacerda CF, de Oliveira ATT, Scapulatempo-Neto C, da Silva SRM, Crema E, Adad SJ, Rodrigues MAM, Henry MACA, Guimarães DP, Longatto-Filho A, Reis RM.

Infect Agent Cancer. 2018 Dec 29;13:43. doi: 10.1186/s13027-018-0216-3. eCollection 2018.

2.

Presence of microsatellite instability in esophageal squamous cell carcinoma associated with chagasic megaesophagus.

Campanella NC, Lacerda CF, Berardinelli GN, Abrahão-Machado LF, Cruvinel-Carloni A, De Oliveira ATT, Scapulatempo-Neto C, Crema E, Adad SJ, Rodrigues MAM, Henry MACA, Guimarães DP, Reis RM.

Biomark Med. 2018 Jun;12(6):573-582. doi: 10.2217/bmm-2017-0329. Epub 2018 Jun 6.

PMID:
29873509
3.

Absence of TERT promoter mutations in colorectal precursor lesions and cancer.

Cruvinel-Carloni A, Yamane L, Scapulatempo-Neto C, Guimarães D, Reis RM.

Genet Mol Biol. 2018 Jan-Mar;41(1):82-84. doi: 10.1590/1678-4685-GMB-2017-0133. Epub 2018 Feb 19.

4.

Mutational profile of TP53 in esophageal squamous cell carcinoma associated with chagasic megaesophagus.

Lacerda CF, Cruvinel-Carloni A, de Oliveira AT, Scapulatempo-Neto C, López RV, Crema E, Adad SJ, Rodrigues MA, Henry MA, Guimarães DP, Reis RM.

Dis Esophagus. 2017 Apr 1;30(4):1-9. doi: 10.1093/dote/dow040.

PMID:
28375484
5.

Copy Number Profiling of Brazilian Astrocytomas.

Bidinotto LT, Torrieri R, Mackay A, Almeida GC, Viana-Pereira M, Cruvinel-Carloni A, Spina ML, Campanella NC, Pereira de Menezes W, Clara CA, Becker AP, Jones C, Reis RM.

G3 (Bethesda). 2016 Jul 7;6(7):1867-78. doi: 10.1534/g3.116.029884.

6.

Cytotoxicity of allitinib, an irreversible anti-EGFR agent, in a large panel of human cancer-derived cell lines: KRAS mutation status as a predictive biomarker.

Silva-Oliveira RJ, Silva VA, Martinho O, Cruvinel-Carloni A, Melendez ME, Rosa MN, de Paula FE, de Souza Viana L, Carvalho AL, Reis RM.

Cell Oncol (Dordr). 2016 Jun;39(3):253-63. doi: 10.1007/s13402-016-0270-z. Epub 2016 Feb 26.

PMID:
26920031
7.

The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.

Batista R, Cruvinel-Carloni A, Vinagre J, Peixoto J, Catarino TA, Campanella NC, Menezes W, Becker AP, de Almeida GC, Matsushita MM, Clara C, Neder L, Viana-Pereira M, Honavar M, Castro L, Lopes JM, Carvalho B, Vaz RM, Máximo V, Soares P, Sobrinho-Simões M, Reis RM, Lima J.

Int J Cancer. 2016 Jul 15;139(2):414-23. doi: 10.1002/ijc.30057. Epub 2016 Mar 24.

8.

TERT promoter mutations in soft tissue sarcomas.

Campanella NC, Penna V, Abrahão-Machado LF, Cruvinel-Carloni A, Ribeiro G, Soares P, Scapulatempo-Neto C, Reis RM.

Int J Biol Markers. 2016 Feb 28;31(1):e62-7. doi: 10.5301/jbm.5000168.

PMID:
26391479

Supplemental Content

Loading ...
Support Center